MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Alpha-synuclein"

  • 2019 International Congress

    Utilising Magnetic Resonance Spectroscopy to investigate synucleinopathies

    N. Khalil, E. Matar, S. Duffy, S. Lewis (Camperdown, Australia)

    Objective: To study the neuronal integrity of the Anterior (ACC) and Posterior (PCC) Cingulate Cortices with Proton Magnetic Resonance Spectroscopy (H-MRS) across healthy controls (n=17),…
  • 2019 International Congress

    Analysis of brain-derived blood exosomes for diagnostics of synucleinopathies

    S. Dutta, I. Rosario, K. Paul, J-A. Palma, S. Perlman, W. Poon, H. Kaufmann, B. Fogel, J. Bronstein, B. Ritz, G. Bitan (Los Angeles, CA, USA)

    Objective: Here, we aimed to determine if measuring of α-synuclein concentration in these vesicles from oligodendrocytes and neurons can distinguish between patients with MSA or…
  • 2019 International Congress

    11C-PBB3 PET in PD: does alpha-synuclein pathology start in axonal terminals?

    M. Matarazzo, A. Pérez-Soriano, V. Sossi, N. Vafai, E. Shahinfard, K. Ju-Chieh Cheng, J. Mckenzie, N. Neilson, Q. Miao, H. Shinotoh, M. Higuchi, A. Stoessl (Vancouver, BC, Canada)

    Objective: To use 11C-PBB3 PET binding to monitor alpha-synuclein (a-syn) pathology in PD subjects in vivo. Background: In previous work we have shown binding of…
  • 2019 International Congress

    Are we underestimating the dysautonomic burden in GBA related a-synucleinopathies?

    G. Lazzeri, E. Monfrini, I. Trezzi, M. Vizziello, M. Percetti, G. Franco, L. Borellini, A. Arighi, A. Di Fonzo (Milan, Italy)

    Objective: The aim of the present study is to understand the prevalence of dysautonomic symptoms in a cohort of Italian glucocerebrosidase (GBA) mutated patients with…
  • 2019 International Congress

    Dissecting the genetic complexity of Parkinson’s disease: a Parkin-GBA study

    Z. Hanss, I. Boussaad, F. Massart, J. Jarazo, R. Krüger (Belvaux, Luxembourg)

    Objective: In this study, we investigate how the PD risk factor GBA would affect the cellular phenotypes associated with homozygous mutations in Parkin, causing an…
  • 2019 International Congress

    A Study of Microglial Metabolism in Neuroinflammation

    T. Domenick, B. Cyr, R. Yost, M. Okun, V. Vedam-Mai (Gainesville, FL, USA)

    Objective: Targeting of microglial metabolism may be a potential therapeutic option for diseases such as PD [Parkinson’s Disease] and LBD [Lewy Body Dementia]. To establish…
  • 2019 International Congress

    Serum uric acid level as a biomarker in sporadic and familial (p.A53T alpha synuclein carriers) Parkinson’s disease: Longitudinal data from the PPMI study

    C. Koros, AM. Simitsi, M. Stamelou, D. Papadimitriou, A. Bougea, I. Pachi, N. Papagiannakis, A. Prentakis, E. Angelopoulou, R. Antonellou, M. Bozi, X. Geronicola Trapali, L. Stefanis (Athens, Greece)

    Objective: To determine whether there are longitudinal differences in serum uric acid level among sporadic Parkinson’s disease (PD) patients, PD patients harboring the p.A53T mutation…
  • 2019 International Congress

    New Neuropathological Staging System for Lewy Body Disease

    J. Toledo, L. Walker, J. Trojanowski, I. Mckeith, J. Attems (Houston, TX, USA)

    Objective: Present the validation of the new proposed novel staging system (NSS) for Lewy body disease and compare it against the previously proposed staging systems. Background:…
  • 2019 International Congress

    Identification and Characterization of Selective and High Affinity Small Molecules as Positron Emission Tomography (PET) Imaging Tracers for Pathological Alpha-Synuclein

    E. Tsika, E. Vokali, J. Molette, M. Ravache, P. Rodriguez, V. Darmency, K. Piorkowska, S. Poli, H. Kroth, F. Capotosti, D. Lowe, J. Stoehr, M. Kosco-Vilbois, A. Pfeifer, A. Muhs (Lausanne, Switzerland)

    Objective: The aim is to develop small molecular weight compounds which bind selectively and with high affinity to alpha-synuclein (a-syn) aggregates as diagnostic PET imaging…
  • 2019 International Congress

    Methylation status of SNCA gene in patients with Parkinson disease in Russian population

    E. Iakovenko, N. Abramycheva, S. Illarioshkin, E. Fedotova (Moscow, Russian Federation)

    Objective: To study methylation status of SNCA gene in patients with Parkinson disease in Russian population Background: The genetic background of Parkinson disease (PD) has…
  • « Previous Page
  • 1
  • …
  • 42
  • 43
  • 44
  • 45
  • 46
  • …
  • 60
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley